Research News and Research

RSS

Dads need to spend more time with kids: Research

According to a new study by the Australian Institute of Family Studies, most Australian kids do not spend much time alone with their dads. The research shows that many kids spend as little as 30 minutes a day with their dads during the week. The Longitudinal Study of Australian Children involved nearly 4,000 people and found that mothers spent more time with the children and preferred it more than fathers.

20 May 2010

Hendra virus infects a horse in south Queensland – authorities fear spread

A horse was put down at Tewantin, near Noosa and it was confirmed that it had Hendra virus infection. At present quarantine measures are being taken.

20 May 2010

Most ER visitors have health insurance of some kind

A National Center for Health Statistics study has found that of the one in five Americans who visit an emergency room every year, most have health insurance.

20 May 2010

Lawmakers probe consumer genetic testing kits

After Pathway Genomics proposed selling genetics tests directly to consumers without Food and Drug Administration approval and "despite concerns" about accuracy, lawmakers have launched an investigation and requested information about the products according to letters sent to three firms by a House panel, The Washington Post reports.

20 May 2010

Hospital deals in New York, Michigan, Tennessee and Georgia

Lenox Hill, a "boutique hospital of choice for the rich" announced Wednesday "that after 153 years as a standalone hospital on the Upper East Side, it was entering a partnership with North Shore-Long Island Jewish Health System, a powerhouse of 15 hospitals and other health care centers in more humble parts of Long Island, Queens and Staten Island."

20 May 2010

Weight Watchers group program helps obese adults lose weight, reduce glucose and insulin levels

The 57 million Americans currently living with "pre-diabetes" could benefit from a group weight loss program, like Weight Watchers, according to a new study published in this month's American Journal of Lifestyle Medicine. Researchers found that after a 6-month Weight Watchers group program, overweight or obese adults who attended at least two thirds of the weekly sessions, not only lost weight, but also significantly reduced fasting glucose and insulin levels - important indicators of diabetes risk.

20 May 2010

FDA panel: Agency should make records of denials public

The Food and Drug Administration's Transparency Task Force has recommended that the agency should make more information available to the public about companies and the FDA's reasons behind decisions not to approve products, Reuters reports. "Wider disclosure could alter companies' ability to control news that could affect their stock prices, especially negative FDA actions such as denying a product or highlighting safety concerns."

20 May 2010

GeoVax Labs spotlighted on interactive map posted on the website of Inc. magazine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, is spotlighted on an interactive map posted on the website of Inc. magazine.

20 May 2010

DMS Health Technologies receives Omega's 2009 NorthFace ScoreBoard Award

DMS Health Technologies announces that it was honored for delivering 'world-class' customer service as a recipient of Omega's 2009 NorthFace ScoreBoard Award for the second consecutive year at the SCORE Conference 2010 on April 29. As rated by its own customers, DMS Health Technologies achieved excellence in customer satisfaction during the prior calendar year for mobile MRI, CT, PET/CT, nuclear medicine, digital mammography, cardiac/angio and bone densitometry services and interim solution rentals; and diagnostic imaging equipment service.

20 May 2010

Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the online-first publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

20 May 2010

TAP to unveil innovative RAFT system at TERMIS Conference

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, is pleased to announce it will be unveiling RAFT (Real Architecture for 3D Tissue), its innovative system for generating reproducible, 3D collagen tissue constructs on TAP Stand 1 at the Tissue Engineering and Regenerative Medicine International Society Conference on June 13-17, in Galway, Ireland.

20 May 2010

Smokers' breath contains 2,5-dimethylfuran

If you smoke, your breath contains 2,5-dimethylfuran. A team of Catalan researchers have proved that the presence of this chemical compound indicates that a person has smoked in the last three days. This substance does not appear in the breath of non-smokers, unless they have been in direct contact with tobacco smoke for a long time.

20 May 2010

GSK, EMBL-EBI, NLM and CDD collaborate to apply principles of open source to drug discovery for malaria

GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.

20 May 2010

RedBrick Health's Employee Health Engagement Survey released

RedBrick Health today released preliminary findings from a national independent survey of benefits decision makers at large to mid-size U.S. companies.

20 May 2010

BIOCIUS and Agilent launch RF360 High Resolution System for high-throughput screening of in vitro ADME assays

BIOCIUS Life Sciences, Inc. and Agilent Technologies Inc. today announced the launch of the RF360 High Resolution System for high-throughput screening of in vitro ADME assays. Combining the accurate mass capabilities of Agilent's time-of-flight (TOF) mass spectrometers and the unprecedented sample processing speed of RapidFire® technology, the instrument revolutionizes in vitro ADME analysis by eliminating the method development bottleneck in drug discovery.

From Evident Corporation - Life Sciences 20 May 2010

Employers must assess current and future retiree prescription benefit options: Medco Health Solutions

As the nation's healthcare system begins to understand and address the impact of the recently enacted healthcare reform legislation, employers must assess their current and future retiree prescription benefit options, according to executives from Medco Health Solutions, Inc. speaking to more than 700 clients at Medco's annual Drug Trend Symposium.

20 May 2010

PurGenesis completes development of novel anti-aging cosmeceutical products

PurGenesis Technologies, Inc. today announced the successful completion of the development of a unique line of anti-aging cosmeceutical products. The product line consists of three unique, anti-aging formulations: Day Cream, Night Cream and Eye Cream.

20 May 2010

Dispelling misconceptions associated with anaesthesia reduce patient anxiety before surgery

Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.

20 May 2010

EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks

The supercomputer Cadmos, installed at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in August of 2009, has bared one of its first fruits: the Laboratory of Multiscale Modeling of Materials has recently developed a computer program the accurately models the complex system of blood flow in the heart for individuals at an unheard-of precision of ten millionths of a meter or ten microns.

20 May 2010

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.

20 May 2010